drugset / Trial / NCT05038787
A Study of LY3473329 in Healthy Japanese Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
The main purpose of this study is to evaluate the safety and tolerability of LY3473329 in healthy Japanese participants. The study will also assess how fast LY3473329 gets into the blood stream and how long it takes the body to remove it. The study is open to healthy participants. The study will last up to about 71 days, inclusive of screening period.
Timeline
- Start
- 2021-11-11
- Primary completion
- 2022-04-07
- Completion
- 2022-04-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Muvalaplin | Small molecule | — | Oral |
Indications
No indication recorded.